AI is no longer a distant concept; it is reshaping industries today. For pharmaceutical companies, the question is clear: how ...
At the cutting edge of drug development, pharmacotherapy is being integrated with software, ushering in a new generation of therapies designed to treat disease more effectively: software-enhanced ...
WALTHAM, Mass.--(BUSINESS WIRE)--Today, Revvity, Inc. (NYSE: RVTY) announced that its software and informatics division, Revvity Signals, will launch Signals Synergy TM, a software solution designed ...
Screen: Pro-ficiency creates clinical trial simulations, filling a gap for the Simulations Plus suite of products. So far, 2024 is shaping up to be a banner year for Simulations Plus Inc. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback